The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Oral Diabetes Medicine Market Research Report 2025
Synopsis
The global Oral Diabetes Medicine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Oral Diabetes Medicine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Oral Diabetes Medicine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Oral Diabetes Medicine include Sanofi, Biocon, Boehringer Ingelheim, Merck & Co., Johnson & Johnson, Novartis, Novo Nordisk, Takeda and AstraZeneca, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Oral Diabetes Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Diabetes Medicine.
Report Scope
The Oral Diabetes Medicine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Diabetes Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Diabetes Medicine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Biocon
Boehringer Ingelheim
Merck & Co.
Johnson & Johnson
Novartis
Novo Nordisk
Takeda
AstraZeneca
Huadong Medicine
Eli Lilly and Company
Deyuan Pharmaceutical
Hengrui Medicine
Segment by Type
DPP-4
GLP-1
SGLT-2
Segment by Application
Type 1 Diabetes
Type 2 Diabetes
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oral Diabetes Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oral Diabetes Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Oral Diabetes Medicine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Oral Diabetes Medicine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Oral Diabetes Medicine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Oral Diabetes Medicine include Sanofi, Biocon, Boehringer Ingelheim, Merck & Co., Johnson & Johnson, Novartis, Novo Nordisk, Takeda and AstraZeneca, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Oral Diabetes Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Diabetes Medicine.
Report Scope
The Oral Diabetes Medicine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Diabetes Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Diabetes Medicine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Biocon
Boehringer Ingelheim
Merck & Co.
Johnson & Johnson
Novartis
Novo Nordisk
Takeda
AstraZeneca
Huadong Medicine
Eli Lilly and Company
Deyuan Pharmaceutical
Hengrui Medicine
Segment by Type
DPP-4
GLP-1
SGLT-2
Segment by Application
Type 1 Diabetes
Type 2 Diabetes
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oral Diabetes Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oral Diabetes Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Oral Diabetes Medicine Market Overview
1.1 Product Overview and Scope of Oral Diabetes Medicine
1.2 Oral Diabetes Medicine Segment by Type
1.2.1 Global Oral Diabetes Medicine Market Value Comparison by Type (2024-2030)
1.2.2 DPP-4
1.2.3 GLP-1
1.2.4 SGLT-2
1.3 Oral Diabetes Medicine Segment by Application
1.3.1 Global Oral Diabetes Medicine Market Value by Application: (2024-2030)
1.3.2 Type 1 Diabetes
1.3.3 Type 2 Diabetes
1.4 Global Oral Diabetes Medicine Market Size Estimates and Forecasts
1.4.1 Global Oral Diabetes Medicine Revenue 2019-2030
1.4.2 Global Oral Diabetes Medicine Sales 2019-2030
1.4.3 Global Oral Diabetes Medicine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Oral Diabetes Medicine Market Competition by Manufacturers
2.1 Global Oral Diabetes Medicine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Oral Diabetes Medicine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Oral Diabetes Medicine Average Price by Manufacturers (2019-2024)
2.4 Global Oral Diabetes Medicine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Oral Diabetes Medicine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oral Diabetes Medicine, Product Type & Application
2.7 Oral Diabetes Medicine Market Competitive Situation and Trends
2.7.1 Oral Diabetes Medicine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Oral Diabetes Medicine Players Market Share by Revenue
2.7.3 Global Oral Diabetes Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oral Diabetes Medicine Retrospective Market Scenario by Region
3.1 Global Oral Diabetes Medicine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Oral Diabetes Medicine Global Oral Diabetes Medicine Sales by Region: 2019-2030
3.2.1 Global Oral Diabetes Medicine Sales by Region: 2019-2024
3.2.2 Global Oral Diabetes Medicine Sales by Region: 2025-2030
3.3 Global Oral Diabetes Medicine Global Oral Diabetes Medicine Revenue by Region: 2019-2030
3.3.1 Global Oral Diabetes Medicine Revenue by Region: 2019-2024
3.3.2 Global Oral Diabetes Medicine Revenue by Region: 2025-2030
3.4 North America Oral Diabetes Medicine Market Facts & Figures by Country
3.4.1 North America Oral Diabetes Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Oral Diabetes Medicine Sales by Country (2019-2030)
3.4.3 North America Oral Diabetes Medicine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Oral Diabetes Medicine Market Facts & Figures by Country
3.5.1 Europe Oral Diabetes Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Oral Diabetes Medicine Sales by Country (2019-2030)
3.5.3 Europe Oral Diabetes Medicine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oral Diabetes Medicine Market Facts & Figures by Country
3.6.1 Asia Pacific Oral Diabetes Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Oral Diabetes Medicine Sales by Country (2019-2030)
3.6.3 Asia Pacific Oral Diabetes Medicine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Oral Diabetes Medicine Market Facts & Figures by Country
3.7.1 Latin America Oral Diabetes Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Oral Diabetes Medicine Sales by Country (2019-2030)
3.7.3 Latin America Oral Diabetes Medicine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Oral Diabetes Medicine Market Facts & Figures by Country
3.8.1 Middle East and Africa Oral Diabetes Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Oral Diabetes Medicine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Oral Diabetes Medicine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Oral Diabetes Medicine Sales by Type (2019-2030)
4.1.1 Global Oral Diabetes Medicine Sales by Type (2019-2024)
4.1.2 Global Oral Diabetes Medicine Sales by Type (2025-2030)
4.1.3 Global Oral Diabetes Medicine Sales Market Share by Type (2019-2030)
4.2 Global Oral Diabetes Medicine Revenue by Type (2019-2030)
4.2.1 Global Oral Diabetes Medicine Revenue by Type (2019-2024)
4.2.2 Global Oral Diabetes Medicine Revenue by Type (2025-2030)
4.2.3 Global Oral Diabetes Medicine Revenue Market Share by Type (2019-2030)
4.3 Global Oral Diabetes Medicine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Oral Diabetes Medicine Sales by Application (2019-2030)
5.1.1 Global Oral Diabetes Medicine Sales by Application (2019-2024)
5.1.2 Global Oral Diabetes Medicine Sales by Application (2025-2030)
5.1.3 Global Oral Diabetes Medicine Sales Market Share by Application (2019-2030)
5.2 Global Oral Diabetes Medicine Revenue by Application (2019-2030)
5.2.1 Global Oral Diabetes Medicine Revenue by Application (2019-2024)
5.2.2 Global Oral Diabetes Medicine Revenue by Application (2025-2030)
5.2.3 Global Oral Diabetes Medicine Revenue Market Share by Application (2019-2030)
5.3 Global Oral Diabetes Medicine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Oral Diabetes Medicine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Oral Diabetes Medicine Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Biocon
6.2.1 Biocon Corporation Information
6.2.2 Biocon Description and Business Overview
6.2.3 Biocon Oral Diabetes Medicine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Biocon Oral Diabetes Medicine Product Portfolio
6.2.5 Biocon Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Corporation Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Oral Diabetes Medicine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Boehringer Ingelheim Oral Diabetes Medicine Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Merck & Co.
6.4.1 Merck & Co. Corporation Information
6.4.2 Merck & Co. Description and Business Overview
6.4.3 Merck & Co. Oral Diabetes Medicine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck & Co. Oral Diabetes Medicine Product Portfolio
6.4.5 Merck & Co. Recent Developments/Updates
6.5 Johnson & Johnson
6.5.1 Johnson & Johnson Corporation Information
6.5.2 Johnson & Johnson Description and Business Overview
6.5.3 Johnson & Johnson Oral Diabetes Medicine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Johnson & Johnson Oral Diabetes Medicine Product Portfolio
6.5.5 Johnson & Johnson Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Oral Diabetes Medicine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Novartis Oral Diabetes Medicine Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 Novo Nordisk
6.6.1 Novo Nordisk Corporation Information
6.6.2 Novo Nordisk Description and Business Overview
6.6.3 Novo Nordisk Oral Diabetes Medicine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novo Nordisk Oral Diabetes Medicine Product Portfolio
6.7.5 Novo Nordisk Recent Developments/Updates
6.8 Takeda
6.8.1 Takeda Corporation Information
6.8.2 Takeda Description and Business Overview
6.8.3 Takeda Oral Diabetes Medicine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Takeda Oral Diabetes Medicine Product Portfolio
6.8.5 Takeda Recent Developments/Updates
6.9 AstraZeneca
6.9.1 AstraZeneca Corporation Information
6.9.2 AstraZeneca Description and Business Overview
6.9.3 AstraZeneca Oral Diabetes Medicine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 AstraZeneca Oral Diabetes Medicine Product Portfolio
6.9.5 AstraZeneca Recent Developments/Updates
6.10 Huadong Medicine
6.10.1 Huadong Medicine Corporation Information
6.10.2 Huadong Medicine Description and Business Overview
6.10.3 Huadong Medicine Oral Diabetes Medicine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Huadong Medicine Oral Diabetes Medicine Product Portfolio
6.10.5 Huadong Medicine Recent Developments/Updates
6.11 Eli Lilly and Company
6.11.1 Eli Lilly and Company Corporation Information
6.11.2 Eli Lilly and Company Oral Diabetes Medicine Description and Business Overview
6.11.3 Eli Lilly and Company Oral Diabetes Medicine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Eli Lilly and Company Oral Diabetes Medicine Product Portfolio
6.11.5 Eli Lilly and Company Recent Developments/Updates
6.12 Deyuan Pharmaceutical
6.12.1 Deyuan Pharmaceutical Corporation Information
6.12.2 Deyuan Pharmaceutical Oral Diabetes Medicine Description and Business Overview
6.12.3 Deyuan Pharmaceutical Oral Diabetes Medicine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Deyuan Pharmaceutical Oral Diabetes Medicine Product Portfolio
6.12.5 Deyuan Pharmaceutical Recent Developments/Updates
6.13 Hengrui Medicine
6.13.1 Hengrui Medicine Corporation Information
6.13.2 Hengrui Medicine Oral Diabetes Medicine Description and Business Overview
6.13.3 Hengrui Medicine Oral Diabetes Medicine Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Hengrui Medicine Oral Diabetes Medicine Product Portfolio
6.13.5 Hengrui Medicine Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oral Diabetes Medicine Industry Chain Analysis
7.2 Oral Diabetes Medicine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oral Diabetes Medicine Production Mode & Process
7.4 Oral Diabetes Medicine Sales and Marketing
7.4.1 Oral Diabetes Medicine Sales Channels
7.4.2 Oral Diabetes Medicine Distributors
7.5 Oral Diabetes Medicine Customers
8 Oral Diabetes Medicine Market Dynamics
8.1 Oral Diabetes Medicine Industry Trends
8.2 Oral Diabetes Medicine Market Drivers
8.3 Oral Diabetes Medicine Market Challenges
8.4 Oral Diabetes Medicine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
